Trial Profile
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Gastro-oesophageal reflux; Heartburn
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 05 Nov 2010 New trial record.